BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33321191)

  • 1. Analysis of Patient-Reported Outcome Utilization Within National Clinical Trials Network Cooperative Group Radiation Oncology Trials Over the Past 2 Decades.
    Howell JN; Anker CJ; Walker AJ; Dorth JA; Kharofa JR
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1151-1160. PubMed ID: 33321191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review.
    Patel K; Ivanov A; Jocelyn T; Hantel A; Garcia JS; Abel GA
    JAMA Netw Open; 2024 Jun; 7(6):e2414425. PubMed ID: 38829615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy: A Systematic Review.
    Fabian A; Domschikowski J; Letsch A; Schmalz C; Freitag-Wolf S; Dunst J; Krug D
    JAMA Netw Open; 2022 Sep; 5(9):e2231930. PubMed ID: 36136335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Reported Outcomes (PROs) used in recent Phase 3 trials for Type 2 Diabetes: A review of concepts assessed by these PROs and factors to consider when choosing a PRO for future trials.
    Reaney M; Elash CA; Litcher-Kelly L
    Diabetes Res Clin Pract; 2016 Jun; 116():54-67. PubMed ID: 27321317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of patient-reported outcomes in advanced breast cancer clinical trials: a review of the published literature.
    Turner-Bowker DM; Hao Y; Foley C; Galipeau N; Mazar I; Krohe M; Globe D; Shields AL
    Curr Med Res Opin; 2016 Oct; 32(10):1709-17. PubMed ID: 27331272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in patient-reported outcome use in early phase dose-finding oncology trials - an analysis of ClinicalTrials.gov.
    Lai-Kwon J; Yin Z; Minchom A; Yap C
    Cancer Med; 2021 Nov; 10(22):7943-7957. PubMed ID: 34676991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons.
    Siddiqui F; Liu AK; Watkins-Bruner D; Movsas B
    J Clin Oncol; 2014 Sep; 32(26):2920-7. PubMed ID: 25113760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare use of patient-reported outcomes in childhood cancer clinical trials - a systematic review of clinical trial registries.
    Riedl D; Rothmund M; Darlington AS; Sodergren S; Crazzolara R; de Rojas T;
    Eur J Cancer; 2021 Jul; 152():90-99. PubMed ID: 34090144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
    Bruner DW; Bryan CJ; Aaronson N; Blackmore CC; Brundage M; Cella D; Ganz PA; Gotay C; Hinds PS; Kornblith AB; Movsas B; Sloan J; Wenzel L; Whalen G;
    J Clin Oncol; 2007 Nov; 25(32):5051-7. PubMed ID: 17991920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of patient-reported outcomes in oncology clinical trials using immune checkpoint inhibitors: A systematic review.
    Malone E; Barua R; Meti N; Li X; Fazelzad R; Hansen AR
    Cancer Med; 2021 Aug; 10(15):5031-5040. PubMed ID: 34184416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective.
    Murugappan MN; King-Kallimanis BL; Reaman GH; Bhatnagar V; Horodniceanu EG; Bouchkouj N; Kluetz PG
    J Natl Cancer Inst; 2022 Jan; 114(1):12-19. PubMed ID: 33930159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions.
    Ganz PA; Gotay CC
    J Clin Oncol; 2007 Nov; 25(32):5063-9. PubMed ID: 17991922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on the expected quality of reporting in SBRT/radiosurgery prospective studies: how far have we come in 30 years?
    Vial N; Nevesny S; Sotton S; Moslemi D; Jmour O; Guillaume E; Rehailia-Blanchard A; Trone JC; Langrand-Escure J; Vallard A; Magne N
    Br J Radiol; 2021 May; 94(1121):20200115. PubMed ID: 33861141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018.
    Reale ML; De Luca E; Lombardi P; Marandino L; Zichi C; Pignataro D; Ghisoni E; Di Stefano RF; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Bironzo P; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
    Lung Cancer; 2020 Jan; 139():47-54. PubMed ID: 31734586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study.
    Jia Y; Li Q; Zhang X; Yan Y; Yan S; Li S; Li W; Wu X; Rong H; Liu J
    J Med Internet Res; 2024 May; 26():e45719. PubMed ID: 38718388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-Related Quality of Life and Patient-Reported Outcomes in Radiation Oncology Clinical Trials.
    Remick JS; Kowalski E; Samanta S; Choi S; Palmer JD; Mishra MV
    Curr Treat Options Oncol; 2020 Aug; 21(11):87. PubMed ID: 32862317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR).
    Mercieca-Bebber R; Williams D; Tait MA; Roydhouse J; Busija L; Sundaram CS; Wilson M; Langford A; Rutherford C; Roberts N; King M; Vodicka E; Devine B;
    Qual Life Res; 2018 Oct; 27(10):2581-2591. PubMed ID: 29915979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Publication status of contemporary oncology randomised controlled trials worldwide.
    Chen YP; Liu X; Lv JW; Li WF; Zhang Y; Guo Y; Lin AH; Sun Y; Mao YP; Ma J
    Eur J Cancer; 2016 Oct; 66():17-25. PubMed ID: 27522246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov.
    Berkman AM; Murphy KM; Siembida EJ; Lau N; Geng Y; Parsons SK; Salsman JM; Roth ME
    Value Health; 2021 Dec; 24(12):1820-1827. PubMed ID: 34838280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of patient-reported outcomes (PROs) and non-PROs in randomized controlled trials addressing head/neck cancers.
    Gode M; Faggion CM
    Cancer Med; 2024 Apr; 13(8):e7036. PubMed ID: 38646947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.